NRT Smoking Cessation Aids in Germany

Summary

Euromonitor International's NRT Smoking Cessation Aids in Germany report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2013 illustrate how the market is set to change.

Product coverage: NRT gum, NRT patches, NRT inhalators, other

Data coverage: market sizes (historic and forecasts), company shares, brand shares

Why buy this report?

• Get a detailed picture of the smoking cessation aids industry
• Pinpoint growth sectors and trends and identify factors driving change
• Understand the competitive environment, the market's major players and leading brands
• Use five-year forecasts to assess how the market is predicted to develop

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor has a unique capability to develop reliable information resources to help drive informed strategic planning

Contents

• NRT Smoking Cessation Aids in Germany
• Euromonitor International
• April 2009
• Executive Summary
• OTC Healthcare - A Stagnating Market
• Smoking Ban Drives NRT Sales
• Changing Distribution System
• Major Brands Gaining Importance
• Mixed Outlook for OTC Healthcare
• Key Trends and Developments
• Economy Stalls, No Recovery Expected Over the Medium Term
• the Decline and Ageing of Germany's Population Continues
• Germany's Changing OTC Retail Environment
• Homeopathy Gaining Ground Against Herbal Products
• Market Indicators
• Market Data
• $1OTC Registration and Classification
• Vitamins & Dietary Supplements Registration and Classification
• EU Legislation
• Self-medication and Preventative Medicine
• Generics
• Definitions
• Beiersdorf AG
• Strategic Direction
• Key Facts
• Company Background
• Production
• Competitive Positioning
• Bayer Vital GmbH
• Strategic Direction
• Key Facts
• Company Background
• Production
• Competitive Positioning
• Boehringer Ingelheim Pharma GmbH & Co Kg
• Strategic Direction
• Key Facts
• Company Background
• Production
• Competitive Positioning
• Johnson & Johnson GmbH
• Strategic Direction
• Key Facts
• Company Background
• Production
• Competitive Positioning
• Mcm Klosterfrau Vertriebsgesellschaft Mbh
• Strategic Direction
• Key Facts
• Company Background
• Production
• Competitive Positioning
• Novartis AG
• Strategic Direction
• Key Facts
• Company Background
• Production
• Competitive Positioning
• Ratiopharm GmbH & Co
• Strategic Direction
• Key Facts
• Company Background
• Production
• Competitive Positioning
• Stada Arzneimittel AG
• Strategic Direction
• Key Facts
• Company Background
• Production
• Competitive Positioning
• Headlines
• Trends
• Competitive Landscape
• Prospects
• Sector Indicators
• Sector Data
• List of Summaries
  • Summary 1 OTC Healthcare Switches 2005-2007
  • Summary 2 Research Sources
  • Summary 3 Beiersdorf AG: Key Facts
  • Summary 4 Beiersdorf AG: Operational Indicators
  • Summary 5 Beiersdorf AG: Competitive Position 2008
  • Summary 6 Bayer Vital AG: Key Facts
  • Summary 7 Bayer Vital AG: Operational Indicators
  • Summary 8 Bayer Vital AG: Production Statistics 2007
  • Summary 9 Bayer Vital AG: Competitive Position 2008
  • Summary 10 Boehringer Ingelheim Pharma GmbH & Co KG: Key Facts
  • Summary 11 Boehringer Ingelheim Pharma GmbH & Co KG: Operational Indicators
  • Summary 12 Boehringer Ingelheim Pharma GmbH & Co KG: Competitive Position 2008
  • Summary 13 Johnson & Johnson GmbH: Key Facts
  • Summary 14 Johnson & Johnson GmbH: Operational Indicators
  • Summary 15 Johnson & Johnson GmbH: Competitive Position 2008
  • Summary 16 MCM Klosterfrau Vertriebsgesellschaft mbH: Key Facts
  • Summary 17 MCM Klosterfrau Vertriebsgesellschaft mbH: Competitive Position 2008
  • Summary 18 Novartis Consumer Health GmbH: Operational Indicators
  • Summary 19 Novartis Consumer Health GmbH: Competitive Position 2008
  • Summary 20 Ratiopharm GmbH & Co: Key Facts
  • Summary 21 Ratiopharm GmbH & Co: Operational Indicators
  • Summary 22 Ratiopharm GmbH & Co: Competitive Position 2008
  • Summary 23 STADA Arzneimittel AG: Key Facts
  • Summary 24 STADA Arzneimittel AG: Operational Indicators
  • Summary 25 STADA Arzneimittel AG: Competitive Position 2008
• List of Tables
  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
  • Table 2 Life Expectancy at Birth 2003-2008
  • Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
  • Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
  • Table 5 OTC Healthcare Company Shares by Value 2004-2008
  • Table 6 OTC Healthcare Brand Shares by Value 2005-2008
  • Table 7 Penetration of Private Label by Sector 2003-2008
  • Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
  • Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
  • Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
  • Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
  • Table 12 Novartis Consumer Health GmbH: Key Facts
  • Table 13 Number of Smokers by Gender 2003-2008
  • Table 14 Sales of Smoking Cessation Aids by Subsector: Value 2003-2008
  • Table 15 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2003-2008
  • Table 16 NRT Gum Flavours: % Value Breakdown 2006-2008
  • Table 17 Smoking Cessation Aids Company Shares by Value 2004-2008
  • Table 18 Smoking Cessation Aids Brand Shares by Value 2005-2008
  • Table 19 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2008-2013
  • Table 20 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2008-2013